Global Low Calcium Peritoneal Dialysis Solution Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Low Calcium Peritoneal Dialysis Solution Market Research Report 2024
Low calcium peritoneal dialysis solution is suitable for patients with chronic renal failure who require continuous ambulatory peritoneal dialysis because non-dialysis treatment is ineffective, and it is only used in the abdominal cavity.
According to Mr Accuracy reports new survey, global Low Calcium Peritoneal Dialysis Solution market is projected to reach US$ 6757.8 million in 2029, increasing from US$ 4519 million in 2022, with the CAGR of 5.9% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Low Calcium Peritoneal Dialysis Solution market research.
The global medical device market is estimated to be US$603.3 billion in 2024, and is expected to grow at a CAGR of 5% over the next six years. At present, global health care expenditure accounts for about 10% of global GDP, and the proportion will continue to increase in the next few years. It is mainly due to the increasing demand for healthcare from an aging population, rising prevalence of chronic and infectious diseases, and expansion in emerging markets. There are many patients with chronic kidney disease in my country, and the treatment rate of patients with end-stage renal failure is low. With the gradual implementation of my country's serious illness medical insurance policy and the increase in reimbursement ratio, the market demand of hemodialysis industry will be greatly released, and peritoneal dialysis is in line with national medical insurance due to its cost-effective advantages policy direction, the market prospect is broad.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Low Calcium Peritoneal Dialysis Solution market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Fresenius Medical Care
Terumo Corporation
Huaren Pharmaceutical
Weihai Weigao Blood Purification Products
Baxter Healthcare
Shijiazhuang NO.4 Pharmaceutical
Chengdu Qingshan Likang Pharmaceutical
Wuhu Daorun Pharmaceutical
Shanghai Changzheng Fumin Jinshan Pharmaceutical
Segment by Type
Lactate-G1.5%
Lactate-G2.5%
Lactate-G4.25%
Acute Renal Failure
Chronic Renal Failure
Acute Drug Or Toxic Intoxication
Refractory Heart Failure
Intractable Edema
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Low Calcium Peritoneal Dialysis Solution report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports new survey, global Low Calcium Peritoneal Dialysis Solution market is projected to reach US$ 6757.8 million in 2029, increasing from US$ 4519 million in 2022, with the CAGR of 5.9% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Low Calcium Peritoneal Dialysis Solution market research.
The global medical device market is estimated to be US$603.3 billion in 2024, and is expected to grow at a CAGR of 5% over the next six years. At present, global health care expenditure accounts for about 10% of global GDP, and the proportion will continue to increase in the next few years. It is mainly due to the increasing demand for healthcare from an aging population, rising prevalence of chronic and infectious diseases, and expansion in emerging markets. There are many patients with chronic kidney disease in my country, and the treatment rate of patients with end-stage renal failure is low. With the gradual implementation of my country's serious illness medical insurance policy and the increase in reimbursement ratio, the market demand of hemodialysis industry will be greatly released, and peritoneal dialysis is in line with national medical insurance due to its cost-effective advantages policy direction, the market prospect is broad.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Low Calcium Peritoneal Dialysis Solution market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Fresenius Medical Care
Terumo Corporation
Huaren Pharmaceutical
Weihai Weigao Blood Purification Products
Baxter Healthcare
Shijiazhuang NO.4 Pharmaceutical
Chengdu Qingshan Likang Pharmaceutical
Wuhu Daorun Pharmaceutical
Shanghai Changzheng Fumin Jinshan Pharmaceutical
Segment by Type
Lactate-G1.5%
Lactate-G2.5%
Lactate-G4.25%
Segment by Application
Acute Renal Failure
Chronic Renal Failure
Acute Drug Or Toxic Intoxication
Refractory Heart Failure
Intractable Edema
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Low Calcium Peritoneal Dialysis Solution report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices